Adverse experiences with implantable defibrillators in Oregon hospices

American Journal of Hospice and Palliative Medicine

Volumn 28, Issue 5, 2011, Pages 304-309

  Fromme, Erik K ^a,d   Stewart, Tanya ^b,c   Jeppesen, Margaret ^d   Tolle, Susan W ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Community Home Health and Hospice ^*  (United States)

^c Evercare   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

adverse effects; cross sectional studies; defibrillators implantable; hospice care; terminal care

Indexed keywords

ARTICLE; DEFIBRILLATOR; HEALTH CARE POLICY; HEALTH CARE SURVEY; HOSPICE; HOSPICE CARE; HUMAN; ORGANIZATION AND MANAGEMENT; PALLIATIVE THERAPY; RESUSCITATION; STATISTICS; UNITED STATES;

CARDIOPULMONARY RESUSCITATION; DEFIBRILLATORS, IMPLANTABLE; HEALTH CARE SURVEYS; HEALTH POLICY; HOSPICE CARE; HOSPICES; HUMANS; OREGON; PALLIATIVE CARE; RESUSCITATION ORDERS;

EID: 80051605307     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909110390505     Document Type: Article

References (24)

1. Harrington MD, Luebke DL, Lewis WR, Aulisio MP, Johnson NJ Implantable cardioverter-defibrillators at end-of-life. Fast Facts and Concepts. http://www.eperc.mcw.edu/fastfact/ff_112.htm. Accessed March 24, 2010.
2. American Heart Association. Implantable cardioverter defibrillator. http://www.americanheart.org/presenter.jhtml?identifier=11227. Accessed March 24, 2010.
3. DiMarco JP Implantable cardioverter-defibrillators. N Engl J Med. 2003;349(19):1836-1847.
4. Zipes D., Camm AJ, Borggrefe M.,et al.ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary. Circulation. 2006;114(10):1088-1132.
5. Moss AJ, Hall WJ, Cannom DS,et al.Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335(26): 1933-1940.
6. Moss AJ, Zareba W., Hall WJ,et al.Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877-883.
7. Hohnloser SH, Kuck KH, Dorian P.,et al.Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351(24):2481-2488.
8. McClellan MB, Tunis SR Medicare coverage of ICDs. N Engl J Med. 2005;20;352(3):222-224.
9. National Hospice and Palliative Care Organization. 2007 National Summary of Hospice Care. http://www.nhpco.org/files/public/Statistics_Research/2007_natl_summary-hospice_care.pdf. Accessed March 24, 2010.
10. Lewis WR, Luebke DL, Johnson NJ,et al.Withdrawing implantable defibrillator shock therapy in terminally ill patients. Am J Med. 2006;119(10):892-896.
11. Berger JT The ethics of deactivating implanted cardioverter defibrillators. Ann Intern Med. 2005;142(8):631-634.
12. Goldstein NE, Lampert R., Bradley E.,et al.Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med. 2004;141(11):835-838.
13. Familydoctor.org. Implantable cardioverter-defibrillator. http://familydoctor.org/online/famdocen/home/common/heartdisease/treatment/270.html. Accessed March 24, 2010.
14. Sola CL, Bostwick JM Implantable cardioverter-defibrillators, induced anxiety, and quality of life. Mayo Clin Proc. 2005; 80(2):232-237.
15. Kirk TW Deactivation of automatic implantable cardioverter-defibrillators in hospice and home care patients at the end of life. Home Healthc Nurse. 2008;26(7):431-437.
16. Lampert R., Hayes DL, Annas GJ,et al.HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm. 2010;7(7): 1008-1026.
17. Sandelowski M. Whatever happened to qualitative description? Res Nurs Health. 2000;23(4):334-340.
18. Goldstein N., Carlson M., Livote E.,et al.Brief Communication: management of implantable cardioverter-defibrillators in hospice: a nationwide survey. Ann Intern Med. 2010;152(5): 296-299.
19. Tilden VP, Tolle SW, Drach LL,et al.Out-of-hospital death: advance care planning, decedent symptoms, and caregiver burden. J Am Geriatr Soc. 2004;52(4):532-539.
20. Goldstein N., Mehta D., Teitelbaum E.,et al.It's like crossing a bridge complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life. J Gen Intern Med. 2008;23(1suppl1):2-6.
21. Kelley AS, Reid MC, Miller DH, Fins JJ, Lachs MS Implantable cardioverter-defibrillator deactivation at the end of life: A physician survey. Am Heart J. 2009;157(4):702-708.
22. Goldstein NE, Bradley E., Zeidman J.,et al.Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients: results of a nationwide survey comparing cardiology specialists to primary care physicians. J Am Coll Cardiol. 2009; 54(4):371-373.
23. Goldstein N., Mehta D., Siddiqui S.,et al."That's Like an Act of Suicide" Patients' Attitudes Toward Deactivation of Implantable Defibrillators. J Gen Intern Med. 2008;23(suppl 1): 7-12.
24. Sherazi S., Daubert J., Block RC,et alPhysicians' preferences and attitudes about end of life care in patients with an implantable cardioverter-defibrillator. Mayo Clinic Proc. 2008;83(10): 1139-1141.